LA CAVA, PIERA
 Distribuzione geografica
Continente #
NA - Nord America 455
EU - Europa 196
AS - Asia 143
AF - Africa 42
SA - Sud America 1
Totale 837
Nazione #
US - Stati Uniti d'America 446
IT - Italia 75
CN - Cina 61
SG - Singapore 59
IE - Irlanda 47
CI - Costa d'Avorio 37
UA - Ucraina 26
VN - Vietnam 14
DE - Germania 10
CA - Canada 9
SE - Svezia 9
RU - Federazione Russa 8
SN - Senegal 5
GB - Regno Unito 4
FI - Finlandia 3
IN - India 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
NL - Olanda 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
FR - Francia 1
KR - Corea 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
Totale 837
Città #
Santa Clara 113
Chandler 81
Singapore 50
Dublin 47
Chicago 44
Abidjan 37
Jacksonville 30
Civitanova Marche 24
Boardman 19
Catania 17
Andover 13
Ashburn 12
Cambridge 12
Dong Ket 12
Lawrence 12
Toronto 7
Wilmington 7
Nanjing 6
Beijing 5
Dakar 5
Hanover 5
Jiaxing 5
Nanchang 5
Shenyang 5
Des Moines 4
San Mateo 4
Bremen 3
Changsha 3
Florence 3
Helsinki 3
Saint Petersburg 3
Biancavilla 2
Brno 2
Brussels 2
Fremont 2
Hanoi 2
Hebei 2
Los Angeles 2
Maracena 2
Ottawa 2
Seattle 2
Syracuse 2
Tianjin 2
Verona 2
Amsterdam 1
Belpasso 1
Bergamo 1
Dalian 1
Dearborn 1
Den Haag 1
Dubai 1
Edinburgh 1
Falls Church 1
Grafing 1
Guangzhou 1
Jinan 1
Lausanne 1
Librizzi 1
Messina 1
Milan 1
Misterbianco 1
Moscow 1
Mumbai 1
Munich 1
New York 1
Noida 1
Redwood City 1
Seoul 1
Stockholm 1
São Paulo 1
Tappahannock 1
Washington 1
Xingtai 1
Totale 651
Nome #
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 76
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 74
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 73
The Apoptotic Machinery As A Biological Complex System: Analysis Of Its Omics And Evolution, Identification Of Candidate Genes For Fourteen Major Types Of Cancer And Experimental Validation in CML And Neuroblastoma 72
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 70
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 67
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 64
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 63
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 58
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 54
Myeloid-derived suppressor cells in Chronic myeloid leukemia 52
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 51
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study 50
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 17
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 15
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 14
Totale 870
Categoria #
all - tutte 3.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 4 5 0 4 2 6 3
2020/202186 1 4 6 6 22 1 13 1 5 0 9 18
2021/202292 8 15 0 1 18 2 13 4 6 0 2 23
2022/2023201 17 24 6 24 12 30 0 32 44 0 7 5
2023/2024120 8 16 3 2 5 33 0 12 0 2 31 8
2024/2025276 7 73 31 32 85 48 0 0 0 0 0 0
Totale 870